|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-12-14
|
|
pubmed:abstractText |
Few studies of the efficacy and safety of therapy with combinations of salmeterol/fluticasone propionate (SFCs) have been conducted in Chinese patients with COPD, and the benefits of combination therapy in nonsmoking patients with COPD are, to our knowledge, not known.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
pubmed-author:ChenPingP,
pubmed-author:HuangShao-GuangSG,
pubmed-author:HuangWen-JieWJ,
pubmed-author:LanYangY,
pubmed-author:SunTie-yingTY,
pubmed-author:VigPP,
pubmed-author:WangChang-ZhengCZ,
pubmed-author:WangGuang-FaGF,
pubmed-author:WenZhong GuangZG,
pubmed-author:WuYa MeiYM,
pubmed-author:XiongSheng-DaoSD,
pubmed-author:ZhengJin-PingJP,
pubmed-author:ZhongNan-ShanNS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
132
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1756-63
|
|
pubmed:meshHeading |
pubmed-meshheading:17951625-Administration, Inhalation,
pubmed-meshheading:17951625-Adult,
pubmed-meshheading:17951625-Aged,
pubmed-meshheading:17951625-Aged, 80 and over,
pubmed-meshheading:17951625-Albuterol,
pubmed-meshheading:17951625-Androstadienes,
pubmed-meshheading:17951625-Bronchodilator Agents,
pubmed-meshheading:17951625-China,
pubmed-meshheading:17951625-Dose-Response Relationship, Drug,
pubmed-meshheading:17951625-Double-Blind Method,
pubmed-meshheading:17951625-Drug Administration Schedule,
pubmed-meshheading:17951625-Drug Therapy, Combination,
pubmed-meshheading:17951625-Female,
pubmed-meshheading:17951625-Forced Expiratory Volume,
pubmed-meshheading:17951625-Humans,
pubmed-meshheading:17951625-Male,
pubmed-meshheading:17951625-Metered Dose Inhalers,
pubmed-meshheading:17951625-Middle Aged,
pubmed-meshheading:17951625-Placebos,
pubmed-meshheading:17951625-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:17951625-Quality of Life,
pubmed-meshheading:17951625-Questionnaires,
pubmed-meshheading:17951625-Smoking,
pubmed-meshheading:17951625-Statistics, Nonparametric,
pubmed-meshheading:17951625-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
|
|
pubmed:affiliation |
Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical College, Guangzhou 510120, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
